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Chronic alcohol exposure increases ganglia
endogenous morphine levels
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Abstract
Introduction: We have previously demonstrated that alcohol has the ability to
release low levels of endogenously expressed, chemically authentic, morphine
from neural tissues. 
Material and methods: Presently, we demonstrate that chronic exposure of
Mytilus edulis pedal ganglia tissues maintained in organotypic culture to very
concentrations of 1 mM and 10 mM ethanol induces a time dependent increase
in both endogenous morphine and dopamine (DA) levels. 
Results: Chronic incubation of M. edulis pedal ganglia with 3 concentrations of
DA resulted in statistically significant elevations of cellular morphine levels,
thereby confirming previous studies from our laboratory establishing DA as an
essential precursor in the morphine biosynthetic pathway. 
Conclusions: By understanding multiple debilitating effects of alcohol on
“morphinergic” signaling, we may understand the ravages of neural processes
associated with alcohol abuse and how its treatment may be made more
effective. 
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Introduction
The positive reinforcing effects of alcohol consumption are mediated
through complex interactions between multiple CNS systems [1-11]. These
systems appear to be functionally entrained within the A10 mesocortical-
mesolimbic DA-ergic cell group. A10 DA neurons have also been implicated
in the development of dependencies to relatively broad spectrum of
addictive compounds including opiates, psychostimulants, and nicotine
[12]. The neurochemical effects of alcohol on A10 neurons appear to be
partially mediated via release of candidate neuromodulators/ neuro  -
transmitters including endogenous opioid peptides, 5-HT, glutamate, GABA,
and acetylcholine [2, 13]. Mechanistically, these same neurochemical
systems represent valid therapeutic targets to curb alcohol cravings and
maintain abstinence in chronic abusers [14-17]. 
In particular, there appear to multiple levels of functional crosstalk
between alcohol, opioid receptors, and A10 DA neurons [18, 19]. For
example, the reinforcing behavioural properties of mu and delta opioid
receptor selective agonists have been functionally mapped to specific
regions of the nucleus accumbens (NAC) and prefrontal cortex [20, 21].
Several lines of evidence indicate alcohol-mediated disruption of normal
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opioid signaling mechanisms within A10 neurons.
These include studies demonstrating direct effects
of alcohol on the binding properties of opioid
receptors, modulation of opioid peptide synthesis
and secretion, and the formation of alcohol-derived
isoquinoline condensation products [22]. The
widespread clinical usage of the mu opioid receptor
antagonist naltrexone for alcohol abuse provides
strong confirmation of intimate functional
relationships of alcohol, opiates, and A10 DA
neurons [14]. 
In light of the discussion presented above, we
have previously demonstrated that alcohol has the
ability to release low levels of endogenously
expressed, chemically authentic, morphine from
various tissues, including those of neural origin [23,
24]. The potential importance of these observations
may lie in their suggestive implications for the
regulatory importance of cellular homeostasis
maintained by ongoing “morphinergic” signaling
events [25-27]. The critical importance of DA as an
essential precursor in the morphine biosynthetic
pathway lends further credence to these
contentions [25-27]. More recent studies from our
laboratory demonstrate that other substances of
abuse (cocaine and nicotine) also appear to have
the ability to release endogenous morphine from
cells and at the same time promote compensatory
synthesis of the alkaloid [23, 24, 28, 29]. 
In sum, previous work from our laboratory has
demonstrated that multiple substances of abuse
have the ability to enhance endogenous morphine
processes at a common step, e.g., release from
cellular stores, in invertebrate and human tissues
[23, 24, 28, 30]. In the present report we further
demonstrate that chronic exposure of neural tissues
to ethanol induces a time dependent increase in
both endogenous morphine and DA levels. By
understanding multiple debilitating effects of
alcohol on “morphinergic” signaling, we may
understand the ravages of neural processes
associated with alcohol abuse and how its
treatment may be made more effective. 
Material and methods
Tissue preparation and pharmacological
treatments
Mytilus edulis were collected from the local
waters of Long Island Sound and maintained as
previously described in detail [31]. Pooled pedal
ganglia from 20 animals were separately incubated
with 1 mM or 10 mM ethanol, or vehicle for 1 h, 2 h,
6 h, 12 h, and 24 h. Ethanol and vehicle treated ganglia
were harvested, washed, and extracted as described
below. In an additional study, pooled pedal ganglia
from 20 animals were separately incubated with
DA at 10–7M, 10–6M, and 10–5M for 18 h. DA treated
ganglia were harvested, washed, and extracted as
described below. 
Extraction of treated pedal ganglia
For morphine and DA analysis, pooled pedal
ganglia samples were dissolved in 1 N HCl and
homogenized by sonication. Tissue homogenates
were extracted with 5 ml chloroform/isopropanol 
9 : 1 for 5 min at 30°. Following centrifugation at
3000 rpm for 15 min, the upper aqueous phase was
reserved for morphine and DA quantification and
vacuum dried using a Centrivap Console (Labconco,
Kansas City, Missouri). Dried extracts were dissolved
in 1 ml 0.05% trifluoroacetic acid (TFA), clarified, and
passed through activated Waters Sep-Pak Plus 
C-18 cartridges. Elution was achieved utilizing an
H2O/CH3CN/TFA solution (89.5% : 10% : 0.05%,
v/v/v). Eluted fractions were dried prior to morphine
and DA analyses. 
RIA quantification of extracted morphine
For analysis of morphine in extracted and dried
fractions, we employed a commercially available RIA
kit obtained from Diagnostic Products Corporation.
The morphine RIA is a solid phase competitive
binding analysis, whereby 125I-labeled morphine
competes for immobilized antibody binding sites
with extracted morphine in the test sample (USA)
[32-36]. The detection limit is 0.5 ng/ml.
Combined HPLC and electrochemical
detection (ECD) of dopamine
The combined HPLC-ECD analyses for DA
quantification were performed with a Waters 626
pump (Waters, Milford, MA) and a C-18 Unijet
microbore column (BAS). A flow splitter (BAS) was
used to provide the low volumetric flow-rates
required for the microbore column. The split ratio
was 1/9. Operating the pump at 0.5 ml/min, yielded
a microbore column flow-rate of 50 µl/min. The
injection volume was 5 µl. Dopamine quantification
was achieved via using amperometric detector 
LC-4C (BAS, West Lafayette, Indiana). The microbore
column was coupled directly to the detector cell to
minimize the dead volume. The electrochemical
detection system used a glassy carbon-working
electrode (3 mm) and a 0.02 Hz filter (500 mV; 
range 10 nA). The cell volume was reduced 
by a 16-µm gasket. The chromatographic system was
controlled by Waters Millennium32 Chro  matography
Manager V3.2 software and the chromatograms were
integrated with Chroma  tograph software (Waters). 
Statistical analysis
A two-way ANOVA was used for statistical
analysis of treated pedal ganglia tissues. Each
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experiment was performed 4 times. The mean
value was combined with the mean value taken
from 4 other replicates. The SEM represents the
variation of the mean of the means. 
Results
Chronic incubation of M. edulis pedal ganglia
maintained in organotypic culture with very low
concentrations of 1 mM or 10 mM ethanol for 1 h,
6 h, 12 h, and 24 h, resulted in statistically
significant elevations of cellular morphine le    vels
(1.74 ±0.73 ng/mg, 5.26 ±0.68 ng/mg, and 
7.39 ±0.94 ng/mg) for 6 h, 12 h, and 24 h,
respectively (Figure 1). In effect, we observed
apparent 200-400% increases in cellular morphine
between 12 h and 24 h incubation with 1 mM or
10 mM. These observations indicate that chronic
incubation with very low concentrations of ethanol
promote cellular biosynthetic mechanisms to
increase endogenous morphine. 
Chronic exposure of invertebrate neural ganglia
to the same low concentrations of ethanol
increased DA levels at the 24 h time point as well
(Figure 2). As depicted in Figure 2, incubation of
M. edulis pedal ganglia with 1 mM or 10 mM
ethanol equivalent to 0.003% v/v and 0.03% v/v,
respectively, for 6 h, 12 h, and 24 h resulted in
a significant elevation of cellular DA levels at the
24 h time point (19.33 ±5.18 ng/mg, 25.83 ±6.54 ng/mg,
and 38.75 ±7.36 ng/mg for 1 mM ethanol at 6 h, 
12 h, and 24 h, respectively). We observed an
apparent 100% increase in cellular DA concen  -
trations after 24hr incubation with 1 mM ethanol
vs. control (17.53 ±6.4 ng/mg vs. 38.75 ±7.36 ng/mg,
respectively). The 24 h increase in cellular DA
concentration is consistent with the role of DA as
an essential precursor in the morphine biosynthetic
pathway [27]. 
Finally, chronic incubation of M. edulis pedal
ganglia maintained in organotypic culture 
with 3 concentrations of DA at 10–7M, 10–6M, 
and 10–5M for 18 h, resulted in statistically
significant elevations of cellular morphine levels: 
4.2 ±1.7 ng/mg, 7.6 ±1.9 ng/mg, 9.3 ±2.5 ng/mg,
respectively (Figure 3). These observations confirm
previous studies from our laboratory establishing
DA as an essential precursor in the morphine
biosynthetic pathway. 
Discussion
In the present report we demonstrate that
chronic exposure of M. edulis neural tissues
maintained in organotypic culture to a very low
concentration of 1 mM ethanol equivalent to
0.003% v/v ethanol induces a time dependent
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Figure 2. Chronic incubation of M. edulis pedal ganglia
maintained in organotypic culture with 1 mM 
or 10 mM ethanol increases cellular DA concen  tra  -
tions. An apparent 100% increase in cellular DA con  -
centrations after 24 h incubation with 1 mM ethanol
vs. control (17.53 ±6.4 ng/mg vs. 38.75 ±7.36 ng/mg,
respectively) was observed
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Figure 3. Chronic incubation of M. edulis pedal
ganglia maintained in organotypic culture with 
3 concentrations of DA at 10–7 M, 10–6 M, and 10–5 M
for 18 h, resulted in statistically significant elevations
of cellular morphine levels (4.2 ±1.7 ng/mg, 
7.6 ±1.9 ng/mg, 9.3 ±2.5 ng/mg)
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Figure 1. Chronic incubation of M. edulis pedal
ganglia maintained in organotypic culture with 1 mM
or 10 mM ethanol increases cellular morphine
concentrations. Statistically significant elevations of
cellular morphine levels of 1.74 ±0.73 ng/mg, 
5.26 ±0.68 ng/mg, and 7.39 ±0.94 ng/mg were
observed at 6 h, 12 h, and 24 h, respectively
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increase in both endogenous morphine and DA
levels. Interestingly, acute 1 hr exposure to the same
concentration of ethanol produces a marked
reduction of endogenous morphine levels by < 50%
vs. controls and is consistent with the ability of
1 mM ethanol to promote evoked release of
morphine into the cell culture medium, including
those involving human white blood cells [23, 24].
Furthermore, these experiments suggest that
a portion of neural DA stores may be targeted for
morphine biosynthesis and are open to phys  -
iological modulation, depending on the parti  cular
type of stimulus. 
Previous studies have shown that CYP2D6 is one
of the key enzymes for morphine biosynthesis in
animals, including human [26, 37]. In support of our
current observations, others have shown that in post
mortem analyses, brain tissues of chronic alcohol
abusers express high levels of CYP2D6 [38]. Thus,
a functional linkage between chronic alcohol exposure
in vivo and endogenous morphine expression may
be mediated via the increased expression of this key
morphine biosynthetic enzyme [37].
Our overall testable hypothesis reciprocally
linking endogenous morphine production and
release to cellular processes necessary for homeo  -
stasis of DA-ergic signaling is supported by 
a gene expression/microarray study of human
genes in primary cultures of human leukocytes
exposed to pharmacological concentrations of
morphine (10–6 M) [39]. Morphine effected
differential changes in mRNA levels of candidate
enzymes involved in DA/catecholamine and/or
endogenous morphine synthesis. We observed an
approximate 50% reduction in tyrosine hydroxylase,
COMT, and CYP2D6 mRNA levels, as compared to
control values. In contrast, levels of L-DOPA
decarboxylase and DA β-hydroxylase (DDC and
DBH, respectively) mRNAs were relatively
unchanged vs. control values, indicating a selective
pharmacological effect of morphine on key enzyme
activities involved in both endogenous morphine
and DA expression in PMNs. Secondary validation
of morphine-mediated changes in the gene
expression/microarray analysis was provided by
real-time Taqman RT-PCR of CYP2D6 mRNA
expression in primary cultures of human PMNs
treated with morphine. The RT-PCR analysis yielded
equivalent reductions in cellular levels of CYP2D6
mRNA of approximately 50%, thereby confirming
the inhibitory effect of morphine on CYP2D6 mRNA
expression monitored by gene expression/
microarray analysis. Furthermore, the study also
demonstrated that the morphine action was
mediated by NO, providing additional support for
the functional linkage of endogenous morphine,
the µ3, and cNOS activation.
In view of the reinforcing properties of alcohol
in combination with the in vitro observations from
our present study, the effects of alcohol on
endogenous morphine and DA expression appear
to be both time and dose dependent. Reciprocally,
preclinical animal studies demonstrate dose-
dependent effects of administered morphine on the
rate alcohol self administration [40, 41]. Finally,
preclinical studies have led to the adoption of opioid
antagonist therapies employing naltrexone for
maintenance of alcohol abstinence in humans [42]. 
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